As of Sep 27
| +0.26 / +4.08%|
The 4 analysts offering 12-month price forecasts for Rockwell Medical Inc have a median target of 5.00, with a high estimate of 12.00 and a low estimate of 3.00. The median estimate represents a -24.70% decrease from the last price of 6.64.
The current consensus among 5 polled investment analysts is to Hold stock in Rockwell Medical Inc. This rating has held steady since September, when it was unchanged from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.